Though some studies have reported the PfGDH concentration in serum of malaria patients including in asymptomatic malaria, usually lies in nanomolar range [46], yet further studies on GDH expression in local clinical samples from malaria patients are required to test the efficacy of GDH as potential biomarker. The gene discussed is GLUD1; the disease is malaria.